Author | David Ritchie, MD, PhD | OncLive

Author | David Ritchie, MD, PhD

Articles

Dr. Ritchie on Immunological Recovery With Venetoclax and Ibrutinib in MCL

March 05, 2020

Video

David Ritchie, MD, PhD, discusses immunological recovery with venetoclax (Venclexta) and ibrutinib (Imbruvica) in mantle cell lymphoma.

Dr. Ritchie on the Rationale of the AIM Trial in Relapsed/Refractory MCL

February 18, 2020

Video

David Ritchie, MD, PhD, discusses the rationale of the AIM trial in relapsed/refractory mantle cell lymphoma (MCL).

Dr. Ritchie on the Immunologic Impact of Long-Term Venetoclax/Ibrutinib in R/R MCL

February 08, 2020

Video

David Ritchie, MD, PhD, discusses the immunologic impact of long-term venetoclax and ibrutinib in relapsed/refractory mantle cell lymphoma.

Dr. Ritchie on Immunological Response to Venetoclax/Ibrutinib in R/R MCL

February 06, 2020

Video

David Ritchie, MD, PhD, discusses the long-term immunological response to the combination of venetoclax and ibrutinib in relapsed/refractory mantle cell lymphoma.

x